Breaking News
Investing Pro 0
Cyber Monday Extended SALE: Up to 60% OFF InvestingPro+ CLAIM OFFER
Close

AstraZeneca PLC (AZN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
11,176.0 -84.0    -0.75%
11:29:36 - Closed. Currency in GBP ( Disclaimer )
  • Volume: 314,091
  • Bid/Ask: 122.0 / 131.0
  • Day's Range: 11,160.0 - 11,268.0
Type:  Equity
Market:  United Kingdom
ISIN:  GB0009895292 
SEDOL:  0989529
AstraZeneca 11,176.0 -84.0 -0.75%

AZN Financial Summary

 
A brief financial summary of AstraZeneca PLC as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

AstraZeneca PLC reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported revenue was USD 10,982 million compared to USD 9,866 million a year ago. Net income was USD 1,640 million compared to net loss of USD 1,652 million a year ago. Basic earnings per share from continuing operations was USD 1.06 compared to basic loss per share from continuing operations of USD 1.1 a year ago. Diluted earnings per share from continuing operations was USD 1.05 compared to diluted loss per share from continuing operations of USD 1.1 a year ago.For the nine months, revenue was USD 33,144 million compared to USD 25,406 million a year ago. Net income was USD 2,387 million compared to USD 459 million a year ago. Basic earnings per share from continuing operations was USD 1.54 compared to USD 0.33 a year ago. Diluted earnings per share from continuing operations was USD 1.53 compared to USD 0.33 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

AZN Income Statement

Gross margin TTM 81.96%
Operating margin TTM 22.55%
Net Profit margin TTM 4.52%
Return on Investment TTM 11.58%
 Total Revenue  Net Income
Period Ending: Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021
Total Revenue 10982 10771 11390
Gross Profit 8941 8942 9111
Operating Income 2282 2021 2808
Net Income 1640 360 386

AZN Balance Sheet

Quick Ratio MRQ 0.56
Current Ratio MRQ 0.81
LT Debt to Equity MRQ -
Total Debt to Equity MRQ 89.02%
 Total Assets  Total Liabilities
Period Ending: Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021
Total Assets 94185 96579 100273 105363
Total Liabilities 59031 60628 63914 66076
Total Equity 35154 35951 36359 39287

AZN Cash Flow Statement

Cash Flow/Share TTM -
Revenue/Share TTM -
Operating Cash Flow  11.79%
 Cash  Net Change in Cash
Period Ending: Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 2930 1248 3232
Cash From Investing Activities -1743 -800 -168
Cash From Financing Activities -1430 -1295 -3740
Net Change in Cash -294 -873 -685
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

AZN Comments

Write your thoughts about AstraZeneca PLC
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Oct 28, 2021 0:25
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Double top in reach
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email